François Ravenelle, PhD Appointed President and CEO of Innospera Pharma to Lead Next Phase of Growth
Article content
MONTREAL — Innospera Pharma Inc. ('Innospera'), a private, near-clinical-stage biotechnology company focused on developing small-molecule modulators of GPR84 and GPR40 to address a broad range of inflammatory and metabolic diseases with high unmet medical needs, today announced the appointment of François Ravenelle, PhD, as President and Chief Executive Officer, effective immediately.
Article content
'With strong preclinical evidence and the potential to address chronic conditions such as idiopathic pulmonary fibrosis, Innospera is uniquely positioned to make a meaningful impact in the field of inflammatory-related conditions.' – François Ravenelle
Dr. Ravenelle is an accomplished biotech leader with over two decades of experience in pharmaceutical R&D and executive management. He most recently served as President and CEO of Inversago Pharma, a clinical-stage company developing therapies based on peripheral CB1 receptor blockade to treat metabolic and fibrotic diseases. Under his leadership, Inversago raised more than $100M, and was acquired by Novo Nordisk for up to approximately $1 billion USD.
Article content
'I'm thrilled to join Innospera at this pivotal stage, as the company moves toward clinical development with a lead asset that shows strong potential for an exceptional balance of safety and efficacy in targeting inflammatory and metabolic pathways,' said Dr. Ravenelle. 'With strong preclinical evidence and the potential to address chronic conditions such as idiopathic pulmonary fibrosis, Innospera is uniquely positioned to make a meaningful impact in the field of inflammatory-related conditions. I'm excited to contribute to the company's next phase of growth.'
Article content
Pierre Laurin, Executive Chairman of the Board, founder and former CEO, commented: 'François' appointment comes at the perfect time following the completion of our seed financing round. His proven leadership and strategic vision will be invaluable as we prepare for clinical development and beyond. Investissement Québec, Seido Capital, and Anges Québec worked synergistically together to support Innospera's vision, based on the strong potential of our lead assets. We are privileged to work in one of the best life science clusters in North America, where innovation is recognized by quality investors, acting together as catalysts for promising endeavours like ours.'
Article content
About Long-term Inflammation
Article content
Systemic inflammation (inflammaging), increases as a consequence of aging contributing to age-related morbidities. Persistent activation of fibrotic pathways and organ dysfunction is markedly more frequent in the elderly (fibroaging). Elderly individuals with chronic disorders tend to develop inflammaging, a condition associated with elevated levels of blood inflammatory markers and increased susceptibility to chronic disease progression. Chronic, low-grade inflammation is a crucial contributor to various age-related pathologies and natural processes in aging tissue, including the lung, kidney, heart, liver, nervous and the musculoskeletal system.
Article content
Article content
Article content
Article content
Article content
Contacts
Article content
Article content
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Toronto Star
12 hours ago
- Toronto Star
Westport Files Preliminary Short Form Base Shelf Prospectus To Replace Expired Base Shelf Prospectus
VANCOUVER, British Columbia, Aug. 15, 2025 (GLOBE NEWSWIRE) — Westport Fuel Systems Inc. ('Westport') (TSX: WPRT / Nasdaq: WPRT) announces it has filed a preliminary short form base shelf prospectus (once filed in final form and received by the relevant Canadian securities regulatory authorities, the 'Shelf Prospectus') with the securities commissions in each of the provinces and territories of Canada, to replace its prior base shelf prospectus that expired on June 18, 2025. The Shelf Prospectus, when made final, will allow Westport to offer up to USD$100,000,000 of common shares, preferred shares, subscription receipts, warrants, debt securities, or units, or any combination thereof (collectively, the 'Securities') during the 25-month period that the Shelf Prospectus will be effective. The Shelf Prospectus will enable Westport to access new capital or issue securities in connection with strategic acquisitions if and when needed. The amount and timing of any future offerings or issuances will be based on the Company's financial requirements and market conditions at that time.
CTV News
15 hours ago
- CTV News
The U.S. plans to build a US$750M fly factory in Texas to stop a flesh-eating cattle parasite
Cowboys push a cow out of its spot to a veterinarian inspection at a ranch that exports livestock to the U.S., in Zamora, northern Mexico, Monday, July 28, 2025. (AP Photo/Fernando Llano) The U.S. plans to build a $750 million factory in southern Texas to breed billions of sterile flies, ramping up its efforts to keep flesh-eating maggots in Mexico from crossing the border and damaging the American cattle industry. Secretary Brooke Rollins announced Friday that the U.S. Department of Agriculture hopes to be producing and releasing sterile male New World screwworm flies into the wild within a year from the new factory on Moore Air Base outside Edinburg, Texas, about 20 miles (32 kilometres) from the border. She also said the USDA plans to deploy US$100 million in technology, such as fly traps and lures, and step up border patrols by 'tick riders' mounted on horseback and train dogs to sniff out the parasite. In addition, Rollins said the U.S. border will remain closed to cattle, horse and bison imports from Mexico until the U.S. sees that the pest is being pushed back south toward Panama, where the fly had been contained through late last year through the breeding of sterile flies there. The U.S. has closed its border to those imports three times in the past eight months, the last in July, following a report of an infestation about 370 miles (595 kilometres) from the Texas border. American officials worry that if the fly reaches Texas, its flesh-eating maggots could cause billions of dollars in economic losses and cause already record retail beef prices to rise even more, fueling greater inflation. The parasite also can infest wildlife, household pets and, occasionally, humans. 'Farm security is national security,' Rollins said during a news conference at the Texas State Capitol in Austin with Texas Gov. Greg Abbott. 'All Americans should be concerned. But it's certainly Texas and our border and livestock producing states that are on the front lines of this every day.' Texas Gov. Greg Abbott speaks to reporters outside the West Wing of the White House, Feb. 5, 2025, in Washington. (AP Photo/Alex Brandon, File) Texas Gov. Greg Abbott speaks to reporters outside the West Wing of the White House, Feb. 5, 2025, in Washington. (AP Photo/Alex Brandon, File) The pest was a problem for the American cattle industry for decades until the U.S. largely eradicated it in the 1970s by breeding and releasing sterile male flies to breed with wild females. It shut down fly factories on U.S. soil afterward. The Mexican cattle industry has been hit hard by infestations and the U.S. closing its border to imports. Mexico's Agriculture ministry said in a statement Friday that Mexico Agriculture and Rural Development Secretary Julio Berdegué Sacristán and Rollins signed a screwworm control action plan. It includes monitoring with fly-attracting traps and establishing that livestock can only be moved within Mexico through government-certified corrals, the statement said. And on the X social media platform, Berdegué said, 'We will continue with conversations that lead to actions that will permit the reopening of livestock exports.' The new fly-breeding factory in Texas would be the first on U.S. soil in decades and represents a ramping up of the USDA's spending on breeding and releasing sterile New World screwworm flies. The sterile males are released in large enough numbers that wild females can't help but mate with them, producing sterile eggs that don't hatch. Eventually, the wild fly population shrinks away because females mate only once in their weekslong lives. In June, Rollins announced a plan to convert an existing factory for breeding fruit flies into one for breeding sterile New World Screwworm flies, as well as a plan to build a site, also on the air base near Edinburg, for gathering flies imported from Panama and releasing them from small aircraft. Those projects are expected to cost a total of US$29.5 million. The Panama fly factory can breed up to 117 million flies a week, and the new Mexican fly factory is expected to produce up to 100 million more a week. Rollins said the new Texas factory would produce up to 300 million a week. She said U.S. President Donald Trump's administration wants to end the U.S. reliance on fly breeding in Mexico and Panama. 'It's a tactical move that ensures we are prepared and not just reactive, which is today what we have really been working through,' Rollins said. In this Jan. 2024 photo provided by The Panama-United States Commission for the Eradication and Prevention of Cattle Screwworms (COPEG), a worker drops New World screwworm fly larvae into a tray at a facility that breeds sterile flies in Pacora, Pana... In this Jan. 2024 photo provided by The Panama-United States Commission for the Eradication and Prevention of Cattle Screwworms (COPEG), a worker drops New World screwworm fly larvae into a tray at a facility that breeds sterile flies in Pacora, Panama. (COPEG via AP) ___ Hanna reported from Topeka, Kansas. Associated Press writer Fabiola Sánchez in Mexico City contributed reporting. John Hanna, The Associated Press
Canada News.Net
2 days ago
- Canada News.Net
Volatile day on Wall Street, major indices finish little changed
NEW YORK, New York - Investors and traders sobered up on Thursday following the Producer Prices Index reading for July which showed wholesale prices increased 0.9 percent, well above the 0.2 percent expected, reigniting inflation fears and denting hopes for a September rate cut by the Fed. "It seems to be reasonably clear at this point that this wasn't enough to get the Fed off of another cut, or get it going on a cutting cycle," Scott Ladner, chief investment officer at Horizon Investments told CNBC Thursday. "I think people are just like, yeah, this was not a great PPI print, certainly not what you want to see. But we're going to want to see a couple of them before we really think that we're getting sort of a reaccelerating inflation environment, which is really the thing that can knock the Fed off course," Ladner said. Stocks were volatile, trading well into the red before bouncing back Thursday, however at the end the major indices were little changed. The Standard and Poor's 500 posted a modest gain, rising 1.96 points to close at 6,468.54, an increase of 0.03 percent. The index continues to hover near record highs, supported by strength in the technology and healthcare sectors. The Dow Jones Industrial Average edged slightly lower, slipping 11.01 points to finish at 44,911.26, a decline of 0.02 percent. Traders noted some profit-taking in cyclical stocks after a strong run earlier in the week. The tech-heavy NASDAQ Composite also ended virtually unchanged, dipping just 1.80 points to 21,711.34—a decline of 0.01 percent. Despite the flat session, the index has held onto most of its recent gains fueled by strong corporate earnings in the AI and semiconductor sectors. Investors are now looking ahead to key economic indicators scheduled for release on Friday, including U.S. consumer sentiment data , which could provide further insight into the direction of monetary policy in the months ahead. Global Forex Markets Mixed on Thursday as U.S. Dollar Strengthens Against Most Majors The global foreign exchange market posted mixed results on Thursday, with the U.S. dollar advancing against most major currencies amid renewed optimism over US economic resilience and expectations of a prolonged interest rate pause by the Federal Reserve. The euro weakened against the greenback, with the EUR/USD pair falling 0.50 percent to trade at 1.1647. The decline came as traders weighed softer-than-expected industrial production data out of the eurozone and looked ahead to key inflation figures due next week. The British pound also slipped versus the dollar. The GBP/USD pair dropped 0.27 percent to 1.3537 as concerns about slowing growth in the UK continued to weigh on sentiment, despite some recent hawkish signals from the Bank of England. In contrast, the U.S. dollar posted gains against the Japanese yen. The USD/JPY pair rose 0.30 percent to 147.81, supported by rising U.S. Treasury yields and dovish commentary from the Bank of Japan regarding future policy tightening. The U.S. dollar similarly strengthened against the Canadian dollar, with the USD/CAD exchange rate climbing 0.39 percent to 1.3812. The Canadian dollar was pressured by a modest dip in crude oil prices and a lack of strong domestic economic data. Against the Swiss franc, the dollar edged higher as well. The USD/CHF pair increased 0.31 percent to 0.8074, continuing a trend that has seen the franc lose ground in recent sessions amid signs of easing inflation in Switzerland. Commodity-linked currencies were broadly weaker. The Australian dollar fell sharply, with AUD/USD down 0.72 percent to 0.6497, pressured by declining iron ore prices and concerns over a slowdown in Chinese demand. The New Zealand dollar also posted a notable decline. The NZD/USD pair dropped 0.87 percent to 0.5919, making it one of the weakest performers of the day as market participants reacted to softer business confidence data and risk-off sentiment in Asia-Pacific markets. Global Stock Markets Mixed on Thursday; European Indices Post Gains While Asia and Pacific Lag Stock markets across the globe closed with mixed results on Thursday, with most major European indices finishing in positive territory, while several key Asian markets ended the session in the red. Canada's S&P/TSX Composite Index underperformed its U.S. counterparts, falling 77.44 points to settle at 27,915.99, a loss of 0.28 percent. Weakness in energy and materials stocks contributed to the decline, as commodity prices pulled back from recent highs. In London, the FTSE 100 edged higher by 12.01 points to close at 9,177.24, a gain of 0.13 percent. Germany's DAX Performance Index saw a more substantial rise, climbing 191.91 points to 24,377.50, an increase of 0.79 percent. France's CAC 40 also performed well, gaining 65.37 points to settle at 7,870.34, up 0.84 percent. The EURO STOXX 50 Index, which tracks leading blue-chip companies in the Eurozone, added 46.45 points, or 0.86 percent, to end at 5,434.70. Similarly, the Euronext 100 Index moved up by 10.34 points to 1,607.63, marking a 0.65 percent increase. Belgium's BEL 20 rose 32.98 points, finishing the day at 4,779.13—up 0.69 percent. In contrast, Asian markets displayed a less optimistic tone. Hong Kong's Hang Seng Index dropped 94.35 points to 25,519.32, a decrease of 0.37 percent. Singapore's STI Index fell 16.24 points to 4,256.52, down 0.38 percent. Australia saw modest gains, with the S&P/ASX 200 advancing by 46.70 points to close at 8,873.80, a 0.53 percent rise. The broader All Ordinaries added 46.00 points, or 0.51 percent, to finish at 9,149.10. China's Shanghai Composite Index ended the day lower by 17.02 points at 3,666.44, a loss of 0.46 percent. India's S&P BSE SENSEX closed marginally higher, gaining 57.75 points to reach 80,597.66, up 0.07 percent. Meanwhile, Indonesia's IDX Composite climbed 38.34 points to 7,931.25—an increase of 0.49 percent. Malaysia's Kuala Lumpur Composite Index slid 5.55 points to 1,581.05, a drop of 0.35 percent. The S&P/NZX 50 Index in New Zealand gained 67.54 points, closing at 12,834.08, up 0.53 percent. South Korea's KOSPI Composite Index was nearly flat, adding just 1.29 points to 3,225.66, a gain of 0.04 percent. Taiwan's TWSE Index dropped by 131.92 points to 24,238.10, a loss of 0.54 percent. Finally, Japan's Nikkei 225 faced the steepest decline among major indices, shedding 625.41 points to finish at 42,649.26, down 1.45 percent on the day. In the Middle East, Israel's TA-125 Index posted a strong session, rising 25.76 points to 3,032.29—up 0.86 percent. Egypt's EGX 30 Index took a sharp fall, declining 278.90 points to 35,576.40, a drop of 0.78 percent. In South Africa, the Top 40 Index ( declined by 49.80 points to close at 5,773.26, down 0.86 percent.
